Know Labs (NYSEAMERICAN:KNW) Shares Up 3.8% – Time to Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) shot up 3.8% on Tuesday . The company traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Performance

The firm has a market capitalization of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83. The firm has a 50 day moving average price of $2.14 and a two-hundred day moving average price of $2.14.

Hedge Funds Weigh In On Know Labs

An institutional investor recently bought a new stake in Know Labs stock. Corient Private Wealth LLC purchased a new position in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned 0.67% of Know Labs as of its most recent filing with the Securities and Exchange Commission (SEC). 23.96% of the stock is owned by institutional investors.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.